Patents/Assignees

Novavax, Inc.

4 patents in portfolio

US11938179utility2024
Methods and Compositions for Inducing Immune Responses Against Clostridium Difficile
0 cites
US11896662utility2024
Multivalent Influenza Nanoparticle Vaccines
0 cites
US11896664utility2024
Corona Virus Vaccine Formulations
0 cites
US11541112utility2023
Coronavirus Vaccine Formulations
0 cites